Table 1. Association between BGN expression and clinicopathological factors of gastric cancer patients.
| Variables | Number of cases | BGN immunostaining | P | |
|---|---|---|---|---|
| Positive(n=95) | Negative(n=27) | |||
| Gender | ||||
| Male | 92 | 73 | 19 | 0.491 |
| Female | 30 | 22 | 8 | |
| Age(years) | ||||
| ≥65 | 29 | 22 | 7 | 0.766 |
| <65 | 93 | 73 | 20 | |
| Tumor differentiation | ||||
| Well to moderate | 43 | 36 | 7 | 0.251 |
| Poor | 79 | 59 | 20 | |
| Tumor location | ||||
| Gastric fundus | 5 | 3 | 2 | 0.226 |
| Gastric corpus | 57 | 48 | 9 | |
| Pylorus | 60 | 44 | 16 | |
| Tumor size | ||||
| ≤5m | 76 | 57 | 19 | 0.327 |
| >5m | 46 | 38 | 8 | |
| T stage | ||||
| T1+T2 | 27 | 17 | 10 | 0.034 |
| T3+T4 | 95 | 78 | 17 | |
| Lymph node metastasis | ||||
| Negative | 40 | 25 | 15 | 0.004 |
| Positive | 82 | 70 | 12 | |
| Distant metastasis | ||||
| Negative | 117 | 90 | 27 | 0.223 |
| Positive | 5 | 5 | 0 | |
| TNM stage | ||||
| I+II | 49 | 33 | 16 | 0.022 |
| III+IV | 73 | 62 | 11 | |
Note: Positive BGN expression included all positive cases, such as weak and strong.